Activation-induced cytidine deaminase (AID) is essential for the class switch recombination (CSR) and somatic hypermutation (SHM) of Ig genes. Originally, AID was postulated to be an RNAediting enzyme, because of its structural homology with a known RNA-editing enzyme, APOBEC1. In support of this idea, AID shares many of the properties of RNA-editing enzymes, including nucleocytoplasmic shuttling and a dependency on de novo protein synthesis. However, it has not been shown whether AID recognizes a specific mRNA and edits it to generate an enzyme involved in CSR or SHM. Here, we examined the association between AID and polyadenylated [poly(A) ؉ ] RNA in vivo, using UV cross-linking coupled with a poly(A) capture method that relies on biotinylated oligo(dT) and streptavidin-conjugated beads. We found that both exogenous AID expressed in transfected CH12 cells and endogenous AID expressed in BL2 cells were associated with poly(A) ؉ RNA. Similar protein-poly(A) ؉ RNA complexes were formed by APOBEC1 and APOBEC3G. However, the interactions of all of these cytidine deaminase family members, including AID, with poly(A) ؉ RNA were indirect. This was expected for APOBEC1, which is known to act through an RNA-interacting cofactor, APOBEC1 complementation factor (ACF). In addition, the carboxy-terminal region of AID, which is essential for class switching, was also required for its interaction with poly(A) ؉ RNA. These results suggest that the CSR activity of AID requires an ACF-like cofactor that specifically interacts with the carboxy-terminal domain of AID.
T
he antibody repertoire generated initially by V(D)J recombination during the ontogeny of B lymphocytes is expanded enormously by the antigen-triggered expression of activationinduced cytidine deaminase (AID), an essential enzyme for the class switch recombination (CSR) and somatic hypermutation (SHM) of Ig genes (1, 2) . Elucidation of the mechanism of AID-mediated gene modification is therefore crucial, not only for understanding adaptive immunity but also for the development of effective vaccinations and advanced therapeutic antibodies, which can be highly beneficial to the management of various conditions, including allergy, autoimmunity, infection, and cancer.
The molecular mechanism by which AID initiates CSR and SHM has been extensively investigated and debated (3, 4) . AID shows its strongest homology with APOBEC1 (5), an RNAediting enzyme that alters ApoB100 mRNA after forming a complex with APOBEC1 complementation factor (ACF), which recognizes the sequence and structure around a specific cytosine in the ApoB100 mRNA (6, 7) . APOBEC1 then deaminates a cytosine in the ApoB100 mRNA to uracil, thereby changing the encoded protein from a low-density lipoprotein carrier to a triglyceride carrier (8) . AID is proposed to be an RNA-editing enzyme as well, and it possesses several properties required for the activity of RNA-editing enzymes (9, 10) . AID shuttles between the nucleus and cytoplasm (11) , and its CSR-inducing activity depends on new protein synthesis (12, 13) . However, it has not been shown whether AID interacts with RNA in vivo or whether it edits a specific mRNA.
On the other hand, AID can deaminate single-stranded DNA in vitro (14) (15) (16) . AID expression in Escherichia coli or yeast also induces abundant mutations of C to T (or G to A) (17, 18) . These observations led to a proposal that AID deaminates cytosines in the Ig genes in vivo, giving rise to U:G mismatches, which are targets for repair by the base excision repair pathway (3, 4) . During this repair, U is removed by uracil DNA glycosylase (UNG), followed by phosphodiester bond cleavage by apurinic/ apyrimidinic endonuclease. However, it has not been demonstrated whether AID actually deaminates cytosines in chromatin DNA. Furthermore, more recently, mutants of AID with little DNA deamination activity were shown to have significant CSR activity (19) . In addition, a mutant UNG with extremely low U-removal activity (0.1% of wild-type) fully rescues the CSR activity in UNG-deficient B cells (20) .
To test the hypothesis that AID is an RNA-editing enzyme, it is essential to examine whether AID associates with mRNA in vivo. In the present study, we used the UV cross-linking method to demonstrate that AID forms a protein-poly(A) ϩ (polyadenylated) RNA complex in vivo (21, 22) . However, carboxyterminal AID mutants, which lack CSR activity (23-25), did not form a protein-poly(A) ϩ RNA complex. We used the same method to show that APOBEC1 and APOBEC3G also formed a protein-poly(A) ϩ RNA complex in vivo. These results reveal that AID possesses yet another property required for it to be an RNA-editing enzyme.
Results and Discussion mRNA Complex Formation of Active AID in CH12F3-2 Cells. To investigate the association between AID and mRNA, we performed UV cross-linking experiments using a murine lymphoma cell line, CH12F3-2, which undergoes efficient CSR from IgM to IgA (26) . CH12F3-2 cells were irradiated with UV light, which triggers the formation of covalent bonds between the RNA and closely interacting proteins, and then lysed with a denaturant. The subsequent purification of the poly(A) ϩ RNA using biotinylated oligo(dT) and streptavidin-conjugated magnetic beads should have captured the protein-mRNA complexes (Fig. 1A) . However, we did not detect AID after elution from the streptavidin beads, probably because the amount of endogenous AID protein in the CH12F3-2 cells was not high enough to be detected by this method (data not shown). We therefore used a stable transfectant line that expressed a fusion protein of mouse AID and the hormone-binding domain of the estrogen receptor (AID-ER). The CSR-inducing activity of AID-ER is activated in these cells by 4-hydroxytamoxifen (4-OHT) (12) . Expression of the AID-ER protein with the expected size was confirmed by immunoblot analysis using anti-ER antibodies (Fig. 1B) .
We first confirmed the validity of this method by testing whether it could capture eukaryotic translation initiation factor 4E (eIF4E), a bona fide RNA-binding protein that binds to the cap structure of mRNA and regulates translation (27) . Immunoblot analysis of the mRNA-bound fraction showed that eIF4E was captured by mRNA in an oligo(dT)-and UV-dependent manner. In contrast, GAPDH, which does not have RNAbinding activity, was not captured at all (Fig. 1C) . These findings indicated that this method could demonstrate the association between a protein and mRNA in vivo. Similarly, immunoblot analysis using anti-ER antibodies showed that the AID-ER protein was captured in an mRNA complex in an oligo(dT)-and UV-dependent manner (Fig. 1C ). In the absence of 4-OHT, less AID-ER was captured in the mRNA complex (Fig. 1D ), indicating that the biologically active state of the AID-ER protein is required for its association with mRNA in B cells.
Indirect Association of APOBEC1 and APOBEC3G with mRNA in Vivo.
To confirm the applicability of the present method for other cell types and proteins, we examined the protein-mRNA complex formation of other members of the APOBEC family in the BL2 human Burkitt's lymphoma cell line (28) . Members of the APOBEC family act on single-stranded nucleic acids (DNA or RNA) and perform various functions (29) . AID belongs to the APOBEC family and has high homology with both APOBEC1 and APOBEC3G (5, 29) . APOBEC3G is known to bind DNA because it inhibits HIV infection by deaminating the viral cDNA (30) . In addition, several recent publications have reported that APOBEC3G associates with RNA (31-34). Among them, it was reported that APOBEC3G exists as a ribonucleoprotein complex in the mRNA processing body (31, 32) . These reports suggest that APOBEC3G may associate in vivo with either DNA or RNA, or both.
To examine the association of APOBEC1 or APOBEC3G with mRNA, AID-deficient BL2 cells (35) were transfected with human APOBEC1 or APOBEC3G tagged with the human ER epitope (SHSLQ KYYIT GEAEG FPATA) ( Fig. 2A) . APO-BEC1 and APOBEC3G were captured as protein-mRNA complexes in an oligo(dT)-and UV-dependent manner (Fig. 2B) . Interestingly, most of the APOBEC1 or APOBEC3G disappeared if the beads were washed with SDS before elution (Fig.  2C ). These results showed that APOBEC1 and APOBEC3G associate with mRNA in vivo, but their interaction seems to be mostly indirect, as expected from APOBEC1's known requirement for ACF to recognize ApoB100 mRNA.
Indirect Association of Endogenous Human AID with mRNA in Vivo.
BL2 cells are constitutively active for SHM in the V region of Ig genes because they spontaneously express abundant AID (25, 35) . We therefore used the BL2 cell line and its AID-deficient derivative (35) to investigate whether endogenous human AID also associates with mRNA in vivo (Fig. 3A) . UV cross-linking experiments showed that the endogenous human AID in the BL2 cells was captured in an oligo(dT)-and UV-dependent manner. As a negative control, the AID Ϫ/Ϫ BL2 cells did not show any band corresponding to AID (Fig. 3B) . The recovery of AID by the streptavidin-conjugated beads was inhibited by the addition of oligo (dA) 20 but not by oligo (dG) 20 , indicating that the capture of AID by the beads occurred through poly(A) ϩ RNA (Fig. 3C) .
We noticed that the sizes of the AID and AID-ER recovered in the UV cross-linking experiments were the same as those of the unmodified proteins ( Fig. 4A and data not shown) . This finding suggested that the detected AID and AID-ER bands were not covalently linked with mRNA, because such a proteinmRNA complex would migrate much more slowly than the unmodified proteins in SDS-PAGE. To confirm this idea, UV cross-linking was performed using the BL2 cell line, followed by washing of the beads with SDS. Immunoblot analysis revealed that the amount of recovered AID was negligible after the beads were washed with SDS (Fig. 4B ), in agreement with the similar experiments using APOBEC1 and APOBEC3G, described above (Fig. 2C) .
To confirm that the association between AID and mRNA was indirect, the cell lysate from UV-irradiated AID Ϫ/Ϫ BL2 cells was mixed with the lysate from nonirradiated AID ϩ/ϩ BL2 cells, before the oligo(dT)-mediated poly(A) ϩ RNA capture. As shown in Fig. 4C , AID was still recovered in an mRNA complex from this mixture of lysates, although the amount of AID recovered was less than from the lysate mixture of UV-irradiated AID ϩ/ϩ BL2 cells and UV-irradiated AID Ϫ/Ϫ BL2 cells. This result indicated that the direct cross-linking of AID to mRNA is not required for them to interact, and that AID associates with an unknown protein that is cross-linked to mRNA, reminiscent of the role of ACF for APOBEC1. An obvious reduction of the band intensity in the mixture containing nonirradiated AID ϩ/ϩ BL2 cells (Fig. 4C, lane 3) compared with that containing UV-irradiated AID ϩ/ϩ cells (Fig. 4C, lane 1) suggested that there was some direct cross-linking of AID to mRNA, which is also the case in the APOBEC1 interaction with ApoB100 mRNA (36) . The association between AID and its putative cofactor protein seems to be very strong, because it is stable in the presence of guanidine; this is not surprising given that AID can oligomerize after being boiled in strong denaturants, such as urea and guanidine (37) .
Human AID Mutants with Defects in the Carboxy-Terminal Region Do
Not Associate with mRNA. To investigate the functional significance of the AID-mRNA complex formation, UV cross-linking was performed using AID mutants. Human AID mutants with defects in the carboxy-terminal region (JP8B, JP8Bdel, and P20), which are specifically deficient in CSR activity (24) , were compared with wild-type AID for their ability to form mRNA complexes. CH12F3-2A cells (38) transfected with ER-tagged mutant AIDs expressed these proteins at comparable levels (Fig.  5A) . UV cross-linking after 4-OHT treatment showed that wild-type human AID-ER was captured in mRNA complexes in an oligo(dT)-and UV-dependent manner, whereas none of the AID mutants associated with mRNA (Fig. 5B) . These results indicated that the association between AID and mRNA requires the carboxy-terminal region of AID, which is also essential for its CSR-inducing activity.
The present study demonstrated that AID associates with mRNA in vivo. However, the method we used did not allow us to identify a specific mRNA interacting with AID, because it captures all of the poly(A) ϩ RNAs. Most of the mRNA complex formation with AID seems to occur indirectly through an unknown cofactor. This association is dependent on the carboxyterminal region of AID, a critical region for its CSR activity, suggesting that AID-mRNA complex formation is functionally important for CSR. Taken together, the results suggest the existence of an mRNA-recognizing cofactor protein for AID that interacts specifically with the carboxy-terminal domain of AID. Identification of the cofactor protein that facilitates the interaction between AID and mRNA, which may be analogous to ACF in APOBEC1-mediated mRNA editing, will provide critical insight into the function of AID in CSR.
Materials and Methods
Cell Lines. The CH12F3-2 cell line was stably transfected with a transgene encoding a fusion protein of mouse AID and the hormone-binding domain of human estrogen receptor ␣ (AID-ER) under the control of a tetracyclinerepressible promoter, to establish the AER cell line, as described by Doi et al. (12) . AID-ER and other ER-fusion proteins were activated by the addition of 1 M 4-OHT to the culture medium. BL2 is a human Burkitt's lymphoma cell line (28) . An AID-deficient BL2 cell line was established as previously described (35) . CH12F3-2A (38) was subcloned from CH12F3-2, a derivative of CH12F3, as previously described (26) . (12), JP8B-ER, JP8Bdel-ER, and P20-ER (24), including an internal ribosome entry site (IRES) and puromycin-resistance gene (Puro), were described previously. Infectious virus was prepared and introduced into CH12F3-2 and BL2 cells as previously described (24) . Infected cells were selected with 0.25 g/mL puromycin and maintained as a bulk population.
Production of Recombinant Retrovirus and Infection. Retroviral vectors for human AID-ER
UV Cross-linking of RNA to Proteins in Vivo. For each UV cross-linking experiment, 2-10 ϫ 10 6 cells were suspended in 2 mL of PBS supplemented with 2% FBS at 4°C. The total cell suspension was pipetted onto a 10-cm dish and irradiated with 60 mJ/cm 2 of UVC (254 nm) by a UV cross-linker (Spectronics), followed by the immediate addition of 8 mL of 4°C PBS supplemented with 2% FBS, then incubation on ice. After centrifugation at 190 ϫ g for 5 min, the cell pellet was lysed with 400 L of GTC extraction buffer (Promega), composed of 4 M guanidine thiocyanate, 25 mM sodium citrate, and 2% ␤-mercaptoethanol, followed by vortexing until complete cell lysis was achieved. The homogenate was transferred to a low DNA and protein binding tube (Sorenson BioScience) and diluted with 800 L of 70°C dilution buffer (Promega), composed of 6ϫ SSC, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, and 0.25% SDS, including 36 pmol of biotinylated oligo(dT) probe (Promega), and incubated at 70°C for 5 min. The mixture was then spun at 20,000 ϫ g for 10 min at room temperature to promote probe annealing and the precipitation of cell debris. The cleared homogenate was then added to a tube containing streptavidin-conjugated magnetic beads (Streptavidin MagneSphere Paramagnetic Particles; Promega) suspended in 600 L of 0.5ϫ SSC. After incubation of the mixture for 2 min at room temperature, the beads were collected by a magnet stand (Promega). The supernatant was removed, and the beads were washed three times with 0.5ϫ SSC, or with 0.5ϫ SSC supplemented with 0.1% SDS for the SDS wash experiment (Fig. 2C and 4B ). After the final wash the SSC was removed, and the beads were suspended in 1ϫ SDS sample buffer containing 0.04 M DTT, then boiled for 3 min. After a brief spin-down, the beads were collected again by the magnet stand, and the supernatant was subjected to SDS-PAGE. Other details are described in the technical manual of the PolyATtract System 1000 (Promega). Contamination of genomic DNA was not detected in a study using the same system (39) .
In the cell mixture experiment (Fig. 4C) , equal cell numbers of wild-type and AID-deficient BL2 cells irradiated with UV light or not irradiated were mixed together and centrifuged. The cell pellet was then lysed with 400 L of GTC extraction buffer. The subsequent procedures were the same as described above.
Immunoblots. The eluates were subjected to SDS-PAGE using 5%-20% gradient precast polyacrylamide gels (Bio-Rad Laboratories). The proteins were electroblotted onto Immobilon-P PVDF membranes (Millipore) and blocked overnight. The blots were then incubated with primary antibodies diluted in Can Get Signal solution (Toyobo) and with HRP-labeled secondary antibodies, each step at room temperature for 1 h. The signals were detected using ECL Plus Western Blotting Detection Reagents (GE Healthcare) and a LAS-3000mini camera (Fuji Film).
Antibodies. Anti-ER polyclonal antibodies HC-20 and the anti-eIF4E monoclonal antibody P-2 were purchased from Santa Cruz Biotechnology. The anti-GAPDH monoclonal antibody MAB374 was purchased from Chemicon International. The anti-AID antibodies #1 are affinity-purified rabbit polyclonal antibodies raised against the N terminus of human AID (24) . The anti-AID antibody MAID-2 (40) is a rat monoclonal antibody that reacts with the Cterminus of human and mouse AID.
Plasmid Construction of APOBEC1 and APOBEC3G. Retrovirus vectors for human APOBEC1 and APOBEC3G with an epitope tag taken from the 20 carboxyterminal residues of human estrogen receptor ␣ (SHSLQ KYYIT GEAEG FPATA) with the IRES-Puro segment were constructed as follows. The coding sequences of APOBEC1 and APOBEC3G were amplified by oligo(dT)-primed RT-PCR using the total RNA purified from AGS human gastric cancer cells and the human peripheral blood of a healthy volunteer, respectively. The primers for APOBEC1 and APOBEC3G were (forward, 5Ј-GAC GAA TTC AGA CAG AGC ACC ATG ACT TCT-3Ј; reverse, 5Ј-GAT GGA TCC CTC CAA GCC ACA GAA GGA 
